A multidisciplinary approach is being considered for managing interstitial lung disease associated with various conditions, including scleroderma and other autoimmune diseases. The management of this condition appears to involve evaluating and treating patients with a range of therapies and imaging techniques. Different guidelines and approaches are being discussed and developed, including those from medical societies, to address the complexities of interstitial lung disease in patients with underlying rheumatic diseases.